GPBAR1 and colitis: LCA supplementation reduced intestinal inflammation in DSS−, TNBS−, and CD45RBhi T cell transfer models of colitis via TGR5 [62] and VDR [190], as well as through the mitigation of epithelial cell apoptosis [191].